Prudential Financial
RARX

Prudential Financial’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Prudential Financial’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-110,660
Closed -$2.65M – 2508
2019
Q3 		$2.65M Sell
110,660
-10,230
-8% -$303K ﹤0.01% 1438
2019
Q2 		$3.63M Buy
120,890
+640
+0.5% +$14.7K 0.01% 1300
2019
Q1 		$2.69M Sell
120,250
-58,580
-33% -$1.26M ﹤0.01% 1445
2018
Q4 		$3.25M Buy
+178,830
New +$2.81M 0.01% 1275

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial's RARX Position: Q4 2019 in Review

Prudential Financial sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 110,660 shares — an estimated $2.65M sold.

Prudential Financial first reported a position in RARX in Q4 2018 and held it in 4 quarters. The position peaked at $3.63M in Q2 2019. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

  • Prudential Financial reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Prudential Financial sold 110,660 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.65M.
  • Prudential Financial first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Prudential Financial's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.63M in Q2 2019.
  • 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Prudential Financial's 13F filing for Q4 2019, filed 11 Feb 2020.